Logo - Indiana State Department of Health Logo - Indiana State Department of Health Indiana State Department of Health
Promoting Interoperability


FREQUENTLY ASKED QUESTIONS

GENERAL QUESTIONS

Question Answer
ISDH Made some changes to the MU web site mm/dd/yyyy, Did any policies change? ISDH MU policies did not change. The website was updated. There have been no changes to the measures in which ISDH is accepting data submissions. Click here
How do I participate in Promoting Interoperability, where do I start? Review the requirements on the CMS webpage based on whether you are an Eligible Professional (EP), Dual- Eligible Hospital, or a Critical Access Hospital. Click here
What is Meaningful Use, and how does it apply to the Medicare and Medicaid promoting interoperability programs? Under the Health Information Technology for Economic and Clinical Health (HITECH Act), which was enacted under the American Recovery and Reinvestment Act of 2009 (ARRA), incentive payments are available to eligible professionals (Eps), critical access hospitals, and legible hospitals that successfully demonstrate meaningful use of certified EHR technology. ARRA specifies three main components of meaningful use: the use of a certified EHR in a meaningful manner; the use of certified EHR technology for electronic exchange of health information to improve quality of health care; and the use of certified technology to submit clinical quality and other measures. For more information on the definition of meaningful use for each year of the program, see the program requirements pages on promoting interoperability website: Click here
How can I access the ISDH Promoting Interoperability Portal? Using your choice of web browser search "ISDH Meaningful Use" select "ISDH MU Home Page. Click here
Who is responsible for completing and submitting attestation for Eligible Professionals or Eligible Hospitals? The ISDH PI Program does not stipulate who should complete the attestation. We recommend that you identify one individual from your hospital or practice who can act as your EHR administrator. The administrator you select is responsible for registration, completing and submitting your attestation.
What are the requirements for previous years? Please review 2018 Program Requirements for Medicare and 2018 Requirements for Medicaid. Click here
Who is Eligible to participate, Professionals or Hospitals? According to CMS both providing you are an Eligible Professional, Dual-Eligible Hospital, or a Critical Access Hospital, using 2015 edition CEHRT requirements of the Promoting Interoperability Program. Click here
Where do I find information on Meaningful Use? CMS and ONC are the Federal agencies responsible for administering Meaningful Use, there are other organizations the provide information. Click here

ELR

Question Answer
Is my site eligible for Stage 2 or Stage 3? To meet Stage 2, facilities need to establish a HL7 VXU type interface with CHIRP and it needs to remain active. Facilities at a minimum need to transmit all administered vaccine data to CHIRP within 7 days of the administered vaccine. Sites with no activity for more than 30 days are set inactive in CHIRP. To meet Stage 3, facilities need to currently meet Stage 2, and Then can enhance their current connection with a QBP query type message. This will allow for bidirectional connection.
Where can I find Guidance on submitting electroninc lab reporting to Public Health? See the HL7 implementation guide at the following link: Click here
What type of information is collected? The Electronic Laboratory Reporting Registry will collect laboratory results from Eligible Hospitals and Critical Access Hospitals on as an example cancer, STD's, Heavy metals including Lead, and communicable diseases.
Indiana Communicable Disease Rules For more information: Click here

CANCER

Question Answer
What is a Cancer Registry? A cancer registry is a date repository that is utilized collect, store, analyze, and interpret cancer data for a define geographical area. The information comes from patients' medical records. All information is kept confidential.
Where does the information on Cancer come from? Most information is received from hospitals with existing cancer registries submitted electronically. Additional information is received from non-registry hospitals (those without cancer registries), independent laboratories, physician offices, and free standing cancer treatment centers.
Are there benefits associated with a cancer registry? Yes, the registry helps determine the number, type and severity of newly diagnosed cancer cases. Helps identify high risk groups and high risk areas with the state for targeting prevention, education, and screenings.

IMMUNIZATION

Question Answer
Immunization Program and MyVaxIndiana For more information: Click here
How do we update our contact information or change email address? Contact information can be updated at the providers request to their program contact.
How do I update my facility information; change of address or contact name? Facility information cannot be changed. If a site name has changed, or an address needs to be updated, please re-enroll the site as a new location
What are my MSH-4 and RXA-11 IDs? Your MSH-4 and RXA-11 facility ID code is assigned by CHIRP with your HL7 user account information. A few vendors also assign their own ID. Please check your HL7 account setup information for your codes. Click here
If I am registered for CHIRP am I also registered for Meaningful Use, and then I am registered for Meaningful Use am I also registered for CHIRP? Registering or enrolling as a provider in CHIRP does not register an attestment. All sites wishing to attest should be enrolled in CHIRP prior to creating an attestment registration.

SYNDROMIC

Question Answer
Where can I find guidance on the required data elements that should be submitted to ISDH by eligible hospitals for syndromic surveillance? Guidance for data elements can be found at. Click here
What is Active Engagement? Active Engagement: Means that the eligible hospital or CAH is in the process of moving towards sending "production data" to a PHA or CDR, or is sending production data to a PHA or CDR.
Active Engagement option 1: Completed registration to submit data: The EH or CAH has registered to submit data with the PHA or, where applicable, the CDR to which the information is being submitted; registration was completed within 60 days after the start of the EHR reporting period; and the EH or CAH is awaiting an invitation from the PHA or CDR to begin testing and validation. This option allows EH or CAHs to meet the measure when the PHA or CDR has limited resources to initiate the testing and validation process. EH or CAHs that have registered in previous years do not need to submit an additional registration to meet this requirement for each EHR reporting period.
Active Engagement option 2: Testing and Validation: The EH or CAH is in the process of testing and validation of the electronic submission of data. EH or CAHs must respond to requests from the PHA or, where applicable, the CDR within 30 days; failure to respond twice within an EHR reporting period would result in that EH or CAH not meeting the measure.
Active Engagement option3: The EH or CAH has completed testing and validation of the electronic submission and is electronically submitting production data to the PHA or CDR.
What is the National Syndromic Surveillance Program? The National Syndromic Surveillance Program (NSSP) is a collaborative effort between individual and organizations from the local, state and federal levels focused on promoting and advancing syndromic surveillance and the timely exchange of syndromic date. Click here
What is Syndromic Surveillance for Meaningful Use? The use of data to identify and predict trends as they are happening, taking the form of analyzing a patients chief complaints as they present for care in the healthcare setting.
What is Syndromic Surveillance? Refers to methods relying on detection of individuals and population health indicators that are discernible before confirmed diagnoses are made. In particular, prior to the laboratory confirmation of an infectious disease, ill persons may exhibit behavioral patterns, symptoms, signs, or laboratory findings that can be tracked through a variety of data sources.